Seeking Alpha

Amedisys (AMED -6.5%) slides after beating on its Q4 EPS but coming up short on revenue. The...

Amedisys (AMED -6.5%) slides after beating on its Q4 EPS but coming up short on revenue. The company also issued a dour outlook for FY13, now expecting an EPS of $0.60 - $0.70 on revenues of $1.425B - $1.45B. The Street view is for an EPS of $0.78 on revenues of $1.516B.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio:

|